SUNPHARMA Weekly Outlook and Analysis: For the Week: (March 07, 2022 – March 11, 2022) BSE: 524715| NSE: SUNPHARMA| ISIN: INE044A01036 | SECTOR: PHARMA Stock...
SUNPHARMA Weekly Outlook and Analysis: For the Week: (Feb 28, 2022 – March 04, 2022) BSE: 524715| NSE: SUNPHARMA| ISIN: INE044A01036 | SECTOR: PHARMA Stock...
SUNPHARMA Weekly Outlook and Analysis: For the Week: (Feb 21, 2022 – Feb 25, 2022) BSE: 524715| NSE: SUNPHARMA| ISIN: INE044A01036 | SECTOR: PHARMA Stock...
SUNPHARMA Weekly Outlook and Analysis: For the Week: (Feb 14, 2022 – Feb 18, 2022) BSE: 524715| NSE: SUNPHARMA| ISIN: INE044A01036 | SECTOR: PHARMA Stock...
SUNPHARMA Weekly Outlook and Analysis: For the Week: (Feb 07, 2022 – Feb 11, 2022) BSE: 524715| NSE: SUNPHARMA| ISIN: INE044A01036 | SECTOR: PHARMA Stock...
On Wednesday’s morning session, Pharma shares were trading lower with their sectoral index trading lower. Shares of Cadila Healthcare down by 0.47 per cent, Dr...
According to the latest U.S. Food and Drug Administration’s (USFDA) Enforcement Report, Indian pharma major such as Lupin, Sun Pharma and Glenmark has decided to...
DUSA Pharmaceuticals, a wholly owned subsidiary of Sun Pharmaceutical Industries Ltd. has received relief from a U.S. court in a patent infringement case. According to...